19. HIỆU QUẢ TĂNG CƯỜNG SỬ DỤNG TÂN DƯỢC SẢN XUẤT TRONG NƯỚC THUỘC PHẠM VI THANH TOÁN BẢO HIỂM Y TẾ TẠI CÁC BỆNH VIỆN CÔNG

Abstract

Objective: The evaluate the effectiveness of Circular 10/2016/TT-BYT in increasing the use of
domestically produced modern drugs within the coverage of the health insurance fund in public
hospitals in Vietnam.
Subjects and methods: In the intervention study, the subject was the list of new drugs under the
payment scope of the Health Insurance fund used at public hospitals 3 times in 2017, 2018, and 2019.
Result: The number of domestic drug items under Circular 10 in 2018 (858 items) and 2019
(821 items) increased compared to 2017 (809 items), but the ratio of domestic drug items in 2017
was higher than the rate of domestic drug items in 2018, 2019, the difference was not statistically
significant (p > 0.05).
Conclusion: Circular 10 has had a specific impact in promoting the substitution of some foreign
drugs with domestic ones that meet the treatment requirements, drug prices and supply capacity.